Back to Authors

Ashraf, Harshad Pannikkaveettil

https://orcid.org/0000-0001-6842-916X

A5036256477 | I4210141865

Mayo Clinic

Hertie Institute for Clinical Brain Research

Citations 1

4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy

Science Translational Medicine | September 2, 2021 | Volume: 13 | Issue: 609 | Pages: No page available

10.1126/scitranslmed.aaz4957 | PMID 34516822

4-Aminopyridine is a potential therapeutic option for a subgroup of patients with KCNA2 -encephalopathy and gain-of-function variants.